Able View Global Inc. - Class B Ordinary Shares (NQ:ABLV)
0.7454
+0.0054
(+0.73%)
Streaming Delayed Price
Updated: 10:45 AM EDT, Apr 20, 2026
Add to My Watchlist
Price and VolumeDetailed Quote
Top NewsMore News
Which stocks are experiencing notable movement on Friday? ↗
April 17, 2026
These stocks have an unusual volume in today's session ↗
April 17, 2026
PerformanceMore NewsRead More
What's going on in today's session ↗
December 05, 2025
On Friday, there are stocks with unusual volume. Let's take a look. ↗
December 05, 2025
The market is filled with gapping stocks in Friday's session. ↗
December 05, 2025
12 Communication Services Stocks Moving In Thursday's Intraday Session ↗
September 11, 2025
12 Communication Services Stocks Moving In Wednesday's Intraday Session ↗
September 10, 2025
12 Communication Services Stocks Moving In Tuesday's Pre-Market Session ↗
September 09, 2025
Which stocks are moving before the opening bell on Monday? ↗
March 17, 2025
Gapping stocks in Tuesday's session ↗
March 11, 2025
Frequently Asked QuestionsIs Able View Global Inc. - Class B Ordinary Shares publicly traded?
Yes, Able View Global Inc. - Class B Ordinary Shares is publicly traded.
What exchange does Able View Global Inc. - Class B Ordinary Shares trade on?
Able View Global Inc. - Class B Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Able View Global Inc. - Class B Ordinary Shares?
The ticker symbol for Able View Global Inc. - Class B Ordinary Shares is ABLV on the Nasdaq Stock Market
What is the current price of Able View Global Inc. - Class B Ordinary Shares?
The current price of Able View Global Inc. - Class B Ordinary Shares is 0.7454
When was Able View Global Inc. - Class B Ordinary Shares last traded?
The last trade of Able View Global Inc. - Class B Ordinary Shares was at 04/20/26 10:45 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
